Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ptak

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Journal of Virology|February 3, 2007
Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombinationMichael D Moore, William Fu, Olga Nikolaitchik, et al.
Viruses|March 26, 2013
Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphismsPhilippe A Gallay, Roger G Ptak, Michael D Bobardt, et al.
The Journal of Biological Chemistry|March 11, 2010
Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replicationXiaojun Wang, Yanxing Han, Ying Dang, et al.
European Journal of Medicinal Chemistry|November 4, 2018
Investigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitorsGuangyan Zhou, Shidong Chu, Ariana Nemati, et al.
Journal of Medicinal Chemistry|August 30, 1996
Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidinesT E Renau, C Kennedy, R G Ptak, et al.
Plos One|August 23, 2012
Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogensNatalia Pripuzova, Richard Wang, Shien Tsai, et al.
Bioorganic & Medicinal Chemistry|December 3, 2016
Enhanced potency of bivalent small molecule gp41 inhibitorsVladimir Sofiyev, Hardeep Kaur, Beth A Snyder, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2002
Molecular evidence of HIV-1 transmission in a criminal caseMichael L Metzker, David P Mindell, Xiao-Mei Liu, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41Ioannis Kagiampakis, Arbi Gharibi, Marie K Mankowski, et al.
Antiviral Chemistry & Chemotherapy|January 6, 2001
Differences in DNA packaging genes and sensitivity to benzimidazole ribonucleosides between human cytomegalovirus strains AD169 and TowneP M Krosky, R G Ptak, M R Underwood, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Journal of Virology|February 3, 2007
Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombinationMichael D Moore, William Fu, Olga Nikolaitchik, et al.
Viruses|March 26, 2013
Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphismsPhilippe A Gallay, Roger G Ptak, Michael D Bobardt, et al.
The Journal of Biological Chemistry|March 11, 2010
Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replicationXiaojun Wang, Yanxing Han, Ying Dang, et al.
European Journal of Medicinal Chemistry|November 4, 2018
Investigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitorsGuangyan Zhou, Shidong Chu, Ariana Nemati, et al.
Journal of Medicinal Chemistry|August 30, 1996
Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidinesT E Renau, C Kennedy, R G Ptak, et al.
Plos One|August 23, 2012
Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogensNatalia Pripuzova, Richard Wang, Shien Tsai, et al.
Bioorganic & Medicinal Chemistry|December 3, 2016
Enhanced potency of bivalent small molecule gp41 inhibitorsVladimir Sofiyev, Hardeep Kaur, Beth A Snyder, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2002
Molecular evidence of HIV-1 transmission in a criminal caseMichael L Metzker, David P Mindell, Xiao-Mei Liu, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41Ioannis Kagiampakis, Arbi Gharibi, Marie K Mankowski, et al.
Antiviral Chemistry & Chemotherapy|January 6, 2001
Differences in DNA packaging genes and sensitivity to benzimidazole ribonucleosides between human cytomegalovirus strains AD169 and TowneP M Krosky, R G Ptak, M R Underwood, et al.
Pageof 9